NCT02942472

Brief Summary

Position of the tip of the inner catheter and air bubbles detection (at time,5min 10min)during embryo transfer influence the pregnancy rate in ICSI cycles .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
94

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2016

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

October 21, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 24, 2016

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

October 24, 2016

Status Verified

October 1, 2016

Enrollment Period

3 months

First QC Date

October 21, 2016

Last Update Submit

October 21, 2016

Conditions

Pregnancy

Keywords

clinical pregnancy rate after embryo transfer

Outcome Measures

Primary Outcomes (1)

  • clinical pregnancy rate

    one and half year

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

prospective observational study

You may qualify if:

  • BMI \< 30 kg/ m2.
  • Between 20 and 35years old.
  • FSH levels on cycle day 3 of \<12 mIU/mL.
  • Both ovaries present deprived of morphological abnormalities and adequately visualized in Transvaginal ultrasound.
  • Grade one or two embryo quality.

You may not qualify if:

  • Hydrosalpinx.
  • Intrauterine lesion.
  • Patients undergoing ET after cryopreservation.
  • Blood present on the catheter during the transfer procedure.
  • A difficult transfer or with a suspicion of touching the fundus.
  • Endometrial thickness less than 8mm.
  • Known allergic reaction against one of the ingredient of the medications used during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

AMR H YEHIA, MD, MRCOG

CONTACT

0020127900014am_helmy77@hotmail.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 21, 2016

First Posted

October 24, 2016

Study Start

October 1, 2016

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

October 24, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will share